Group One Trading, L.P. Aspira Women'S Health Inc. Transaction History

Group One Trading, L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.32 - $0.58 $908 - $1,647	-2,840 Reduced 45.36%	3,421 $1,000
Q4 2022 Feb 09, 2023	SELL	$0.3 - $0.41 $7,537 - $10,301	-25,126 Reduced 80.05%	6,261 $2,000
Q2 2022 Aug 11, 2022	SELL	$0.4 - $1.09 $3,620 - $9,865	-9,051 Reduced 22.38%	31,387 $18,000
Q1 2022 May 12, 2022	BUY	$0.88 - $1.81 $24,151 - $49,675	27,445 Added 211.23%	40,438 $42,000
Q4 2021 Feb 11, 2022	SELL	$1.63 - $3.43 $4,572 - $9,621	-2,805 Reduced 17.76%	12,993 $23,000
Q3 2021 Nov 12, 2021	BUY	$3.19 - $5.48 $9,289 - $15,957	2,912 Added 22.6%	15,798 $51,000
Q2 2021 Aug 10, 2021	BUY	$4.78 - $6.84 $61,595 - $88,140	12,886 New	12,886 $72,000

431K

Ticker AWH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 124,296,000
Market Cap $123M
Description
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gyneco...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.